Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

BACKGROUND: Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation between...

Descripción completa

Detalles Bibliográficos
Autores principales: McEvoy, Ashleigh C., Warburton, Lydia, Al-Ogaili, Zeyad, Celliers, Liesl, Calapre, Leslie, Pereira, Michelle R., Khattak, Muhammad A., Meniawy, Tarek M., Millward, Michael, Ziman, Melanie, Gray, Elin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038195/
https://www.ncbi.nlm.nih.gov/pubmed/29986670
http://dx.doi.org/10.1186/s12885-018-4637-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038195/
https://www.ncbi.nlm.nih.gov/pubmed/29986670
http://dx.doi.org/10.1186/s12885-018-4637-6

Ejemplares similares